Oxcarbazepine and Scopolamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxcarbazepine (oxcarbazepine) and Scopolamine (scopolamine). Common drug interactions include cerebral disorder among females and disseminated intravascular coagulation among males.

The phase IV clinical study analyzes what interactions people have when they take Oxcarbazepine and Scopolamine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Oxcarbazepine?

Oxcarbazepine has active ingredients of oxcarbazepine. It is often used in epilepsy. eHealthMe is studying from 15,495 Oxcarbazepine users. Check the latest studies of Oxcarbazepine.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.

On Jul, 26, 2026

21 people who take Oxcarbazepine and Scopolamine together, and have interactions are studied.

Oxcarbazepine and Scopolamine drug interactions.

What are the common drug interactions of Oxcarbazepine and Scopolamine, by gender? *:

female:

Cerebral disorder (brain disease)
Ejection fraction decreased (systolic heart failure)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Left ventricular dysfunction
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Death
Fatigue (feeling of tiredness)

male:

Disseminated intravascular coagulation (systemic activation of blood coagulation)
Abdominal pain upper
Fatigue (feeling of tiredness)
Haemoglobin decreased
Kidney transplant rejection
Mydriasis (a dilation of the pupil)
Oxygen saturation decreased
Pupillary reflex impaired
Pyrexia (fever)
Renal vessel disorder (disease of kidney vessel)

What are the common drug interactions of Oxcarbazepine and Scopolamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Chronic respiratory failure
Developmental delay
Emergency care
Hospitalisation
Insomnia (sleeplessness)

20-29:

Fatigue (feeling of tiredness)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Blood pressure decreased
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Bruxism (habitual grinding of the teeth, typically during sleep)
Depressed level of consciousness
Dyskinesia (abnormality or impairment of voluntary movement)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Haemoglobin decreased
Kidney transplant rejection

30-39:

Cataract (clouding of the lens inside the eye)

40-49:

n/a

50-59:

Cerebral disorder (brain disease)
Ejection fraction decreased (systolic heart failure)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Left ventricular dysfunction
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Death
Drug ineffective

60+:

n/a

What are the existing conditions these people have? *

Hypersensitivity: 6 people, 28.57%
Inflammation: 5 people, 23.81%
Abdominal Distension: 5 people, 23.81%
Body Temperature Increased: 5 people, 23.81%
Cardiac Failure: 5 people, 23.81%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 23.81%
Diarrhea: 5 people, 23.81%
Haemostasis (stopping of bleeding): 5 people, 23.81%
High Blood Pressure: 5 people, 23.81%
Wheezing (a high-pitched whistling sound made while you breath): 5 people, 23.81%

* Approximation only. Some reports may have incomplete information.

Do you take Oxcarbazepine and Scopolamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously